While there have been efforts in standardizing histological diagnostic categorization for de novo as well as treatment-induced prostate cancer variants with NE/SC characteristics [3], some CRPC tumors that lost AR dependence may not show typical morphological and immunohistochemical characteristics. This evidence concerns the gene AR and prostate carcinoma.